Introduction {#Sec1}
============

Numerous studies have shown that breast density, as assessed through mammography, is an important breast cancer risk factor \[[@CR1]--[@CR5]\]. Relative to the lowest classification of breast density (fatty tissue), women with the highest classification (extreme density) may have a 2- to 6-fold increased risk of breast cancer \[[@CR5]--[@CR8]\]. In addition to its role in breast cancer risk, breast density reduces mammographic accuracy \[[@CR9]--[@CR12]\], potentially increasing the risk of a later stage breast cancer diagnosis.

Previous studies indicate that established breast cancer risk factors, including family history of breast cancer, age at first birth, parity, and postmenopausal hormone use, have similar associations with breast density. In contrast, the influence of age at menarche, which in most studies is inversely related to breast cancer risk \[e.g., [@CR13]--[@CR15]\], remains uncertain. Some studies have found positive associations \[[@CR6], [@CR16], [@CR17]\], at least one suggests an inverse association \[[@CR18]\], and others found no relation between age at menarche on breast density \[[@CR19], [@CR20]\].

In an effort to clarify inconsistent results from previous studies, we evaluated established breast cancer risk factors in relation to breast density in a large population of women enrolled in a statewide mammography registry. Our intention was to determine whether characteristics associated with breast cancer risk were also related to breast density, a finding that would be consistent with the notion that density mediates breast cancer risk. We were particularly interested in assessing the influence of menarcheal age.

Methods {#Sec2}
=======

The New Hampshire Mammography Network (NHMN) registers all consenting women who undergo mammography at participating mammographic facilities in our state. Details of the registry have been described previously \[[@CR21], [@CR22]\]. For the present study, potentially eligible women were NH residents of ages 30--89, who had at least one mammogram registered in the NHMN from 1 May 1996 to 20 June 2002.

The epidemiological data used in this analysis arose from three sources: a self-administered questionnaire completed by the patient, a patient intake form administered face-to-face by the radiologic technologist, and a standardized clinical assessment form completed by the radiologist. The questionnaire collected height, weight, place of birth, ethnicity, marital status, education, insurance coverage, reason for the current visit, past history of clinical breast examinations and mammography, age at menarche, parity, and age at first birth. The questionnaire also queried women regarding the date of their last menstrual period and history of gynecological surgery. This information was used to classify women as premenopausal (still having periods naturally) or postmenopausal (periods had stopped permanently) either naturally, because of chemotherapy/radiation, or surgery). The patient intake form obtained date of birth, family history of breast cancer (in the subject's mother, sister, daughter, or other relative), personal history of breast cancer, history of breast procedures, type of exam conducted at current visit, examination outcomes, recommendation for further work-up or follow-up, and current use of postmenopausal hormone therapy (HT). The clinical assessment form obtained the type of exam conducted at current visit, breast density, examination outcomes and recommendation for further work-up or follow-up. All three forms are completed during the woman's first NHMN mammography visit. Patient intake and clinical assessment forms are also completed at subsequent mammography visits, and the questionnaire is updated as possible.

Breast density, the outcome variable, estimates the proportion of fibroglandular tissue in the breast, relative to fat. Breast density was recorded on the standardized clinical assessment form by interpreting radiologists using the American College of Radiology Breast Imaging Reporting and Data System^®^ (BI-RADS^®^) classification (1 = fatty, 2 = scattered density, 3 = heterogeneously dense, and 4 = extremely dense) \[[@CR23]\]. In the event of discordance in the density of the right and left breast, the woman was classified according to the higher density classification. Breast density readings were available for 162,933 (95.4%) of the 170,815 women who had at least one mammogram recorded in the registry.

To optimize temporal correspondence between the women's characteristics and the classification of breast density, the statistical analyses were, when possible, based on the woman's breast density on the date of the first recorded mammogram. When data for variables (other than HT use) were unavailable for the date of the mammogram, we searched forward in the NHMN records to retrieve replacement information corresponding to a subsequent mammography visit. Informative forward searches retrieved information from subsequent mammographic encounters occurring, on average, within 24 months of the index mammogram, and reduced missing values by 3--9%.

Current body mass index (BMI; kg/m^2^) was missing for 18,195 women, and the analyses were confined to 144,018 women for whom this measure was available. Included in the analytic sample were 131,480 (91%) women with a screening mammogram, 10,885 (8%) with a diagnostic mammogram, and 1,653 (1%) for whom the reason for the mammogram was not recorded. The majority of women, 136,283 (95%) had no personal history of breast cancer, 6,033 (4%) had a prior history of breast cancer based on NHMN records or the patient intake form, and 1,702 (1%) had unknown breast cancer status.

We used unconditional logistic regression analyses to generate odds ratios (OR) and 95% confidence intervals (CI) \[[@CR24]\] for the association between factors and breast density, dichotomized as heterogeneously/extremely dense (dense) or fatty/scattered density (not dense). Statistical significance required a probability value of \<0.05 (two-sided test). OR were computed using the cutpoints shown in the tables. Tests of trend and the corresponding OR were based on the categorical (age at menarche) or the continuous form of the variable (age, BMI, age at first birth, parity), in accordance with the method of data collection.

Because breast density was inversely associated with age (*p* for trend \<0.0001) and current BMI (*p* for trend \<0.0001), terms for these variables, using the continuous form, were included in all models. We found no evidence of confounding by the other variables shown in Table [1](#Tab1){ref-type="table"} (fully adjusted OR were within 10% of those adjusted for age and BMI). Model building began with terms representing the main effects, and included interaction terms involving age, BMI, and menopausal status as suggested by visual inspection of the stratified analyses. The presence of statistical interactions was formally tested using likelihood ratio tests. The interaction term representing BMI was defined as BMI ≥30 (high BMI), versus \<30 (low BMI). The final multivariable model, based on all women, contained terms for age and BMI in their continuous form, BMI (high, low), family history of breast cancer, age at menarche, age at first birth, parity, menopausal status, current use of HT, and terms for the interactions involving BMI (high, low) and age at menarche, age at first birth, and parity, a term for the interaction involving age and current HT use, and a term for the interaction between age at first birth and menopausal status. We repeated the analyses in parous women, in women with a screening mammogram, and in women who did not have a personal history of breast cancer. Table 1Distribution of women's characteristics by breast density, dichotomized as dense versus not denseCharacteristics of study sample (*n* = 144,018)Not denseDense*n*%*n*%*Age (years)*    30--396,728810,01116    40--4924,9703129,95448    50--5921,5372713,59722    60--6915,160195,4339    70--7910,349133,0395    80--892,47637741    All women81,2205662,79844*Education*    \<High school6,88782,7034    High school graduate27,4853417,29128    College graduate35,2704331,11350    Post graduate9,9711210,68117    Missing1,60721,0102*Marital status*    Not married25,2353116,90527    Married54,1816744,59871    Missing1,80421,2952*Current BMI*    \<202,64036,47910    20--22.499,8481216,57026    22.5--24.9915,4801916,06026    25--27.4914,266189,81216    27.5--29.9912,689166,35310    30--34.9915,197195,3268    35+11,100142,1984*Family history breast cancer*    No55,5916841,23466    Yes25,6293221,56434*Age at menarche*    \<116,13083,0945    1114,028179,32815    1220,9282615,83325    1322,0242718,28129    149,430128,53414    15+7,41396,83011    Missing1,26728981*Age at first birth*^a^    \<2015,537218,55415    20--2430,5744118,67434    25--2916,6942214,27626    30--346,03886,70512    35+1,97232,4784    Missing4,52665,0269*Parity*    05,87987,08511    17,02397,66512    219,7912418,26229    317,6522213,03221    411,723146,90511    5+13,795175,8969    Missing5,35773,9536*Menopausal status*    Premenopausal29,1323637,55460    Postmenopausal46,8745821,89535    Missing5,21463,3495*HT use*^b^    No32,8296312,86751    Yes16,3383110,72242    Missing2,92161,6557^a^Age at first birth in parous women^b^A small proportion of women (5.5%) who reported whether they used HT did not give their menopausal status

Results {#Sec4}
=======

In all women, scattered density (45%) was most frequently recorded, followed by heterogeneous density (34%), fatty breasts (12%), and extremely dense breasts (10%). The distribution of factors by breast density, classified as not dense versus dense, is shown in Table [1](#Tab1){ref-type="table"}. In general, based on the cutpoints shown, there was a tendency for younger women, those with higher education, and married women to have denser breasts. Women with lower BMI also had greater breast density, consistent with our use of BI-RADS categories, which assess the proportion of fibroglandular tissue (versus fat) in the breast. Women with a family history of breast cancer, later menarcheal age, later age at first birth, and low parity had a tendency toward higher breast density. High breast density was more common in premenopausal than in postmenopausal women, and in women currently using HT compared to nonusers.

Age-stratified analyses, adjusted for age and BMI, showed a weak, positive influence of family history of breast cancer across all age groups assessed (Table [2](#Tab2){ref-type="table"}). A small positive association between age at menarche and breast density appeared to vary by age, with weaker effects in the older and youngest age groups. There were no clear age-related patterns for either the positive effect of age at first birth or the inverse effect of parity or menopausal status. Current HT use, compared to nonuse, was inversely associated with breast density in the younger age groups, and positively associated in women of age 50 or more. In women of age 70 or more, those using HT, compared to nonusers, had twice the odds of having dense breasts. Table 2Odds ratios (OR) and 95% confidence intervals (CI) for the association with breast density according to age groupCharacteristic^a^Age group\<4040--4950--5960--6970+*n* = 16,739*n* = 54,924*n* = 35,134*n* = 20,593*n* = 16,628OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)*Family history breast cancer*    NoReferenceReferenceReferenceReferenceReference    Yes1.06 (0.99, 1.13)1.10 (1.06, 1.14)1.07 (1.02, 1.13)1.10 (1.03, 1.18)1.11 (1.02, 1.20)*Age at menarche*    Overall OR (95% CI)^b^1.04 (1.01, 1.06)1.06 (1.05, 1.08)1.03 (1.02, 1.05)1.01 (0.99, 1.03)1.01 (0.98, 1.03)    *p* for trend^b^0.002\<0.00010.00010.310.70    \<11ReferenceReferenceReferenceReferenceReference    110.99 (0.85, 1.18)1.14 (1.04, 1.24)1.28 (1.15, 1.42)1.06 (0.90, 1.24)1.11 (0.89, 1.38)    121.04 (0.89, 1.21)1.15 (1.06, 1.25)1.26 (1.15, 1.39)1.12 (0.96, 1.30)1.18 (0.96, 1.45)    131.15 (0.98, 1.35)1.25 (1.16, 1.36)1.27 (1.15, 1.40)1.20 (1.03, 1.39)1.00 (0.82, 1.23)    141.21 (1.02, 1.44)1.34 (1.22, 1.46)1.37 (1.23, 1.53)1.23 (1.05, 1.46)1.22 (0.99, 1.51)    15+1.29 (1.08, 1.55)1.45 (1.32, 1.60)1.36 (1.21, 1.52)1.05 (0.89, 1.25)1.15 (0.92, 1.43)*Age at first birth*^c^    Overall OR (95% CI)^d^1.08 (1.06, 1.10)1.05 (1.04, 1.06)1.07 (1.06, 1.08)1.07 (1.05, 1.09)1.06 (1.05, 1.08)    *p* for trend^d^\<0.0001\<0.0001\<0.0001\<0.0001\<0.0001    \<20ReferenceReferenceReferenceReferenceReference    20--241.06 (0.95, 1.19)1.14 (1.08, 1.21)1.21 (1.14, 1.29)1.23 (1.12, 1.34)1.07 (0.93, 1.24)    25--291.09 (0.98, 1.22)1.19 (1.12, 1.26)1.40 (1.30, 1.51)1.51 (1.36, 1.68)1.28 (1.11, 1.49)    30--341.35 (1.18, 1.53)1.23 (1.15, 1.36)1.58 (1.42, 1.76)1.64 (1.39, 1.95)1.42 (1.18, 1.70)    35+1.67 (1.30, 2.16)1.48 (1.35, 1.63)1.85 (1.58, 2.17)1.90 (1.44, 2.49)1.47 (1.14, 1.91)*Parity*    Overall OR (95% CI)^d^0.86 (0.84, 0.88)0.91 (0.90, 0.93)0.90 (0.86, 0.91)0.89 (0.87, 0.90)0.87 (0.85, 0.89)    *p* for trend^d^\<0.0001\<0.0001\<0.0001\<0.0001\<0.0001    0ReferenceReferenceReferenceReferenceReference    10.74 (0.65, 0.86)0.90 (0.83, 0.87)0.87 (0.79, 0.97)0.87 (0.73, 1.05)0.88 (0.73, 1.05)    20.58 (0.52, 0.66)0.73 (0.69, 0.78)0.77 (0.71, 0.85)0.77 (0.67, 0.89)0.66 (0.57, 0.78)    30.48 (0.42, 0.55)0.69 (0.65, 0.74)0.67 (0.61, 0.73)0.65 (0.57, 0.76)0.59 (0.51, 0.69)    40.49 (0.42, 0.57)0.61 (0.57, 0.66)0.61 (0.55, 0.67)0.55 (0.48, 0.64)0.49 (0.42, 0.58)    5+0.38 (0.33, 0.45)0.60 (0.55, 0.66)0.52 (0.47, 0.58)0.49 (0.42, 0.56)0.39 (0.33, 0.46)*Menopausal status*    PremenopausalReferenceReferenceReference    Postmenopausal0.69 (0.60 , 0.79 )0.71 ( 0.68, 0.75)0.71 (0.67, 0.75)N/AN/A*HT use*    NoReferenceReferenceReferenceReferenceReference    Yes0.69 (0.57, 0.84)0.80 (0.75, 0.86)1.39 (1.32, 1.46)1.82 (1.70, 1.95)2.02 (1.84, 2.22)^a^Adjusted for age and current BMI as continuous variables^b^Based on the cutpoints shown^c^Among parous women^d^Based on the continuous form of the variable

Analyses stratified on BMI suggested that the influence of some factors was less evident in women of BMI ≥30 (high BMI) than in those of BMI \<30 (low BMI) (Table [3](#Tab3){ref-type="table"}). In particular, the positive influence of age at menarche and age at first birth, and the inverse influence of parity were least apparent in the highest BMI group. The data suggested an inverse effect of being postmenopausal, relative to premenopausal, which decreased consistently across the BMI groupings, but the change in OR from the lowest to the highest BMI group was slight. Although the influence of current HT use fluctuated somewhat over BMI groups, there were no obvious patterns. Table 3Odds ratios (OR) and 95% confidence intervals (CI) for the association with breast density according to BMI groupCharacteristic^a^Current BMI\<22.522.5--25.4925.5--27.4927.5--29.99≥30*n* = 35,547*n* = 37,153*n* = 18,744*n* = 18,775*n* = 33,799OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)*Family history of breast cancer*    NoReferenceReferenceReferenceReferenceReference    Yes1.09 (1.03, 1.14)1.03 (0.99, 1.08)1.08 (1.01, 1.15)1.15 (1.08, 1.23)1.09 (1.03, 1.15)*Age at menarche*    Overall OR (95% CI)^b^1.04 (1.03, 1.06)1.05 (1.03, 1.06)1.04 (1.02, 1.06)1.03 (1.01, 1.05)1.01 (0.99, 1.03)    *p* for trend^b^\<0.0010.0010.0010.0040.25    \<11ReferenceReferenceReferenceReferenceReference    111.25 (1.09, 1.43)1.17 (1.05, 1.31)1.13 (0.98, 1.31)1.20 (1.05, 1.38)1.10 (0.99, 1.22)    121.36 (1.20, 1.55)1.26 (1.13, 1.40)1.10 (0.96, 1.27)1.16 (1.01, 1.32)1.09 (0.98, 1.21)    131.43 (1.26, 1.63)1.33 (1.20, 1.48)1.16 (1.01, 1.33)1.21 (1.06, 1.38)1.06 (0.94, 1.16)    141.54 (1.34, 1.75)1.44 (1.28, 1.61)1.25 (1.08, 1.45)1.19 (1.02, 1.38)1.16 (1.02, 1.31)    15+1.52 (1.32, 1.75)1.43 (1.27, 1.61)1.26 (1.07, 1.48)1.33 (1.13, 1.56)1.06 (0.93, 1.21)*Age at first birth*^c^    Overall OR (95% CI)^d^1.08 (1.07, 1.09)1.07 (1.06, 1.08)1.07 (1.06, 1.09)1.06 (1.04, 1.07)1.03 (1.02, 1.04)    *p* for trend^d^\<0.0001\<0.0001\<0.0001\<0.0001\<0.0001    \<20ReferenceReferenceReferenceReferenceReference    20--241.21 (1.13, 1.31)1.20 (1.13, 1.28)1.15 (1.05, 1.26)1.13 (1.03, 1.23)1.04 (0.96, 1.11)    25--291.39 (1.29, 1.51)1.34 (1.25, 1.44)1.21 (1.10, 1.34)1.31 (1.19, 1.45)1.10 (1.01, 1.19)    30--341.45 (1.32, 1.60)1.55 (1.42, 1.70)1.40 (1.23, 1.59)1.42 (1.25, 1.63)1.11 (0.99, 1.24)    35+1.79 (1.56, 2.06)1.84 (1.61, 2.09)1.88 (1.56, 2.28)1.62 (1.33, 1.97)1.29 (1.08, 1.53)*Parity*    Overall OR (95% CI)^d^0.86 (0.85, 0.87)0.88 (0.87, 0.89)0.90 (0.88, 0.92)0.91 (0.89, 0.93)0.93 (0.92, 0.95)    *p* for trend^d^\<0.0001\<0.0001\<0.0001\<0.0001\<0.0001    0ReferenceReferenceReferenceReferenceReference    10.75 (0.67, 0.84)0.80 (0.73, 0.89)0.93 (0.81, 1.08)1.13 (0.98, 1.30)0.95 (0.85, 1.07)    20.61 (0.55, 0.66)0.67 (0.62, 0.73)0.74 (0.66, 0.84)0.90 (0.79, 1.02)0.85 (0.78, 0.94)    30.52 (0.48, 0.58)0.58 (0.53, 0.63)0.68 (0.60, 0.77)0.80 (0.71, 0.91)0.81 (0.73, 0.89)    40.44 (0.39, 0.48)0.52 (0.47, 0.57)0.60 (0.52, 0.69)0.71 (0.62, 0.81)0.75 (0.68, 0.84)    5+0.37 (0.34, 0.41)0.44 (0.40, 0.48)0.52 (0.45, 0.60)0.64 (0.56, 0.74)0.66 (0.59, 0.74)*Menopausal status*    PremenopausalReferenceReferenceReferenceReferenceReference    Postmenopausal0.67 (0.63, 0.72)0.68 (0.64, 0.72)0.71 (0.65, 0.77)0.73 (0.67, 0.79)0.75 (0.70, 0.80)*HT use*    NoReferenceReferenceReferenceReferenceReference    Yes1.23 (1.15, 1.31)1.33 (1.26, 1.42)1.34 (1.23, 1.46)1.41 (1.30, 1.55)1.34 (1.25, 1.45)^a^Adjusted for age and current BMI as continuous variables^b^Based on the cutpoints shown^c^Among parous women^d^Based on the continuous form of the variable

Analyses stratified by menopausal status revealed largely similar results for most variables, but the relationship between age at first birth and breast density was stronger in the postmenopausal women (Table [4](#Tab4){ref-type="table"}). Table 4Odds ratios (OR) and 95% confidence intervals (CI) for the association with breast density according to menopausal statusCharacteristic^a^Menopausal statusPremenopausalPostmenopausal*n* = 66,686*n* = 68,769OR (95% CI)OR (95% CI)*Family history of breast cancer*    NoReferenceReference    Yes1.09 (1.05, 1.13)1.08 (1.04, 1.12)*Age at first birth*    Overall OR (95% CI)1.05 (1.04, 1.06)1.03 (1.02, 1.04)    *p* for trend\<0.0001\<0.0001    \<11ReferenceReference    111.12 (1.03, 1.21)1.15 (1.06, 1.25)    121.12 (1.04, 1.22)1.20 (1.12, 1.30)    131.22 (1.13, 1.32)1.21 (1.12, 1.31)    141.31 (1.21, 1.43)1.29 (1.18, 1.40)    ≥151.40 (1.28, 1.53)1.25 (1.15, 1.36)*Age at first birth*^b^    Overall OR (95% CI)^c^1.05 (1.05, 1.06)1.07 (1.06, 1.08)    *p* for trend^c^\<0.0001\<0.0001    \<20ReferenceReference    20--241.07 (1.01, 1.13)1.21 (1.15, 1.27)    25--291.11 (1.05, 1.17)1.41 (1.33, 1.49)    30--341.21 (1.13, 1.29)1.57 (1.45, 1.71)    ≥351.48 (1.35, 1.62)1.77 (1.57, 2.00)*Parity*    Overall OR (95% CI)^c^0.90 (0.87, 0.91)0.88 (0.88, 0.89)    *p* for trend^c^\<0.0001\<0.0001    0ReferenceReference    10.87 (0.81, 0.93)0.86 (0.79, 0.93)    20.70 (0.66, 0.74)0.72 (0.68, 0.77)    30.63 (0.60, 0.68)0.62 (0.58, 0.67)    40.57 (0.53, 0.62)0.55 (0.51, 0.59)    ≥50.52 (0.49, 0.57)0.46 (0.43, 0.50)*HT use*    NoNAReference    YesNA1.47 (1.41, 1.52)^a^Adjusted for age and current BMI as continuous variables^b^Among parous women^c^Based on the continuous form of the variable

We assessed risk factors and potential interactions in a multivariable model (Table [5](#Tab5){ref-type="table"}). Only one factor, family history of breast cancer, which showed a weak but significant positive effect (OR 1.09; 95% CI 1.05--1.14) on breast density, was not involved in an interaction. The possible interaction involving age and age at menarche, suggested by the age-stratified analyses, was not statistically significant (*p* = 0.10). A statistically significant interaction was found between current HT use and age (*p* \< 0.0001). Interactions were also present between BMI and age at menarche (*p* = 0.04), age at first birth (*p* \< 0.0001), and parity (*p* = 0.01). We also noted a significant interaction between menopausal status and age at first birth (*p* = 0.004), but the coefficients were inconsistent across categories of age at first birth. When the interaction between menopausal status and age at first birth was omitted from the multivariable model, results for the remaining terms were essentially unchanged. A possible interaction involving age, menopausal status, and HT was not significant (*p* = 0.10). Table 5Betas (*β*) and standard errors (SE) for the association between factors and breast density in all women and in subgroups^a^CharacteristicAll women *n* = 144,018Women without breast cancer *n* = 136,283*β* (SE)*β* (SE)Intercept4.82 (0.17)4.88 (0.17)Age−0.04 (0.001)−0.04 (0.001)Current BMI−0.12 (0.003)−0.12 (0.003)Family history of breast cancer0.09 (0.02)0.09 (0.02)BMI \<30−0.53 (0.11)−0.53 (0.11)Postmenopausal−0.43 (0.09)−0.43 (0.09)HT use−1.22 (0.11)−1.25 (0.11)Age at menarche    15+−0.01 (0.10)−0.03 (0.11)    140.04 (0.10)0.01 (0.10)    13−0.01 (0.08)−0.03 (0.08)    120.08 (0.08)0.06 (0.08)    110.04 (0.08)0.02 (0.08)BMI \<30 \* Age at menarche    15+0.30 (0.12)0.32 (0.12)    140.24 (0.11)0.28 (0.11)    130.22 (0.09)0.24 (0.10)    120.12 (0.09)0.15 (0.10)    110.11 (0.10)0.14 (0.10)Age at first birth    Nulliparous0.38 (0.16)0.13 (0.17)    35+0.19 (0.22)0.25 (0.23)    30--34−0.19 (0.15)−0.18 (0.15)    25--29−0.11 (0.12)−0.12 (0.12)    20--240.14 (0.11)0.13 (0.11)BMI \<30 \* Age at first birth    Nulliparous0.57 (0.10)0.59 (0.11)    35+0.41 (0.18)0.40 (0.18)    30--340.31 (0.11)0.32 (0.12)    25--290.12 (0.08)0.15 (0.08)    20--240.06 (0.06)0.06 (0.06)Postmenopausal \* Age at first birth    Nulliparous0.09 (0.15)0.10 (0.15)    35+−0.08 (0.19)−0.14 (0.19)    30--340.27 (0.13)0.26 (0.13)    25--290.25 (0.11)0.23 (0.11)    20--24−0.05 (0.10)−0.04 (0.11)Parity^a^    10.29 (0.09)0.28 (0.09)    20.22 (0.07)0.23 (0.07)    30.14 (0.07)0.17 (0.07)    40.09 (0.07)0.11 (0.08)BMI \<30 \* Parity^b^    10.30 (0.10)0.30 (0.10)    20.22 (0.07)0.20 (0.08)    30.18 (0.08)0.15 (0.08)    40.09 (0.08)0.07 (0.09)Age \* HT use0.03 (0.002)0.03 (0.002)^a^Based on a multivariable model containing all terms shown in the table^b^The nulliparous parameter and its interaction with BMI were set to 0, since these variables were linear combinations of other variables

We repeated the analyses in the subgroup of women who did not have a personal history of breast cancer, and found similar results (Table [5](#Tab5){ref-type="table"}). The findings were also comparable when the analyses were confined to parous women, or to those with a screening mammogram (data not shown).

Discussion {#Sec5}
==========

Evidence accumulating for nearly 30 years supports the association between breast density and breast cancer \[[@CR1]--[@CR5]\]. Although the notion remains controversial, breast density may be a biomarker of risk \[[@CR25]\]. In addition to its influence on breast cancer risk, breast density reduces the accuracy of screening mammography \[[@CR11], [@CR12], [@CR26], [@CR27]\], particularly in younger women \[[@CR9]\] who tend to have denser breasts \[[@CR28]\]. Perhaps as a direct consequence of reduced screening accuracy, breast density is associated with increased risk of interval breast cancers \[[@CR11]\], with an adverse impact on breast cancer prognosis.

Most studies of breast cancer risk have shown an inverse effect of age at menarche \[[@CR13]--[@CR15], [@CR29]\], but previous studies of the relationship between age at menarche and breast density have produced inconsistent results. A positive association was seen in two studies \[[@CR16], [@CR18]\], including a large HMO population of nearly 30,000 women in Seattle \[[@CR16]\]. Studies of breast cancer family members \[[@CR17]\], Singaporean women \[[@CR20]\], and Hispanic women \[[@CR19]\] found no association between menarcheal age and breast density. Findings from the HMO-based study suggested the positive effect of age at menarche was stronger in the youngest and oldest age groups \[[@CR16]\], whereas a study of nearly 5,000 women in Guernsey found significant positive effects only in postmenopausal women \[[@CR6]\]. In contrast, our age-stratified analyses suggested weaker effects in the oldest age groups, although the interaction involving age and age at menarche was not statistically significant. Also in this study, analyses stratified on BMI suggested that age at menarche was positively associated with breast density in most BMI groups, but the association was tenuous in women with high BMI, and the interaction involving age at menarche and high BMI was statistically significant. A positive association between age at menarche and breast density, even if confined to women with lower BMI, seems paradoxical, given the usual inverse association between age at menarche and breast cancer and the strong positive association between breast density and breast cancer risk.

Consistent with some \[[@CR16]--[@CR18], [@CR20], [@CR30], [@CR31]\], but not all \[[@CR6], [@CR19]\] previous efforts, our findings show that age at first birth and parity are generally associated with breast density in a pattern resembling known associations with breast cancer risk. However, our stratified analyses indicate that the influence of the reproductive variables is less pronounced in women with high BMI, and our modeling results confirmed interactions involving BMI and both variables. These findings, along with our findings for age at menarche, are consistent with the possibility that hormonal or reproductive events are less influential in heavier women, whose circulating hormone levels may be influenced by conversion in peripheral adipose tissue. We also noted a stronger positive influence of age at first birth in postmenopausal women, although a previous study of Native American women found stronger effects in premenopausal women \[[@CR30]\]. Our sample was large, and the multivariable results were inconsistent across categories of age at first birth; thus, it is possible the interaction between menopausal status and age at first birth was due to statistical artifact rather than true effect modification.

Only one variable, family history of breast cancer, was not involved in interactions with age, BMI, or menopausal status. Although previous studies have not shown an effect of family history on breast density \[[@CR3], [@CR6], [@CR19]\], this is likely due to limited power to detect a weak association. The modest inverse effect of menopausal status has been noted previously \[[@CR19], [@CR20], [@CR30]\]. Most previous reports, although not all \[[@CR20]\], found a positive association between use of HT and breast density \[[@CR16], [@CR17], [@CR19], [@CR30], [@CR32], [@CR33]\], resembling the well-known association between use of these hormones and breast cancer risk. The large size of our study allowed an assessment of HT use in young postmenopausal women, and these analyses showed a modest but significant inverse effect in postmenopausal women less than 50 years of age, a phenomenon that has no clear explanation. In women of age 50 or more, the positive effect of HT on density increased with age, perhaps reflecting a corresponding decrease in density in untreated women in the same age group. Consistent with our findings, at least two previous studies of breast density showed an increasing effect of HT use when examined over increasing age groups \[[@CR16], [@CR32]\]. A prospective study of breast cancer risk also noted stronger HT effects in older women \[[@CR37]\], although this is not always seen \[[@CR36]\]. The age-related increase observed in our study could potentially reflect a longer duration of HT use, but at least two studies have shown that most of the increase in breast density occurs soon after HT initiation \[[@CR33], [@CR34]\], and duration of use was not associated with increased breast density in the HMO study \[[@CR16]\]. In contrast, the positive influence of HT on breast cancer risk is usually observed for current/recent and long-term use \[[@CR35]--[@CR40]\]. While speculative, it is possible that sustained breast density associated with long term HT use mediates the relationship between HT and breast cancer risk. Finally, our data did not indicate a stronger effect of HT on breast density in leaner woman, but a few studies \[[@CR38]--[@CR40]\], including a collaborative analysis of 51 studies \[[@CR38]\], suggested a stronger association between HT and breast cancer risk in leaner women.

Although the type of HT used (estrogen alone or estrogen combined with progesterone) was not assessed in our study, a possible role of progesterone is suggested by reports that breast density is greater during the luteal phase of the menstrual cycle \[[@CR41]--[@CR43]\]. In addition, at least two studies have found substantially greater changes in parenchymal patterns in women initiating use of a combined estrogen plus progesterone hormone regimen, as opposed to single agent estrogen \[[@CR33], [@CR34]\]. Results from the Women's Health Initiative randomized clinical trials of postmenopausal hormones also indicate that the increased risk of breast cancer is due to the combined regimen \[[@CR44]\] rather than single agent estrogen \[[@CR45]\].

Strengths of our study include the large size of our sample, allowing analyses stratified by relatively refined age and BMI groups, which has not been possible in most previous studies, and good representation of the underlying population. Epidemiologic data were obtained on the time of the mammographic visit, ensuring updated information, and importantly, a high level of correspondence between use of hormone replacement therapy and the assessment of breast density. Limitations of our study include 11% of women for whom BMI is missing, reliance of self-report for BMI, and a lack of information regarding the type and duration of HT use. Our definition of family history of breast cancer included second degree relatives, which may have attenuated the effect of this variable. Also, the BI-RADS scores are qualitative, as opposed to digital quantification of density, and were applied by community radiologists, who despite being trained to use this system, may apply it differently. Nevertheless, our general findings in terms of the direction of effects for reproductive factors and HT use were compatible with those of most previous studies.

In conclusion, our results, based on the largest study to date, confirm earlier findings that most established breast cancer risk factors behave similarly in relation to breast density, consistent with the notion that breast density mediates breast cancer risk. However, our data indicated an inverse effect of HT in younger women, and a positive influence in older women, which has not been reported previously. We also noted effect modification by BMI, in which the positive effects of age at menarche and age at first birth, and the inverse effects of parity were less apparent in heavier women. Further investigation, including biological studies, may elucidate the complex interrelationships of hormones, BMI, breast density, and breast cancer and potentially offer opportunities for breast cancer prevention.
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